Not Enrolling Enough? How To Rescue Your Recruitment

A common issue regarding “faltering” studies – studies that are not satisfying their time, cost, and quality parameters – is poor recruitment. Recruitment issues can delay deadlines and jeopardize the drug’s ultimate approval, if left unresolved. These delays are a big deal, since every day that is delayed can cost sponsors up to $8 million in lost sales. If your study is struggling because of recruitment issues, here are some considerations that can be used to rescue your clinical trial